In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity-Reference-Cited by-同舟云学术

In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity

Published:2000-09 Issue:17 Volume:7 Page:1467-1476
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Sun Y,Peng D,Lecanda J,Schmitz V,Barajas M,Qian C,Prieto J

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301264.pdf

Reference46 articles.

1. Noelle RJ, Ledbetter JA, Aruffo A . CD40 and its ligand, an essential ligand–receptor pair for thymus-dependent B cell activation Immunol Today 1992 13: 431–433

2. Grewal IS, Flavell RA . CD40 and CD154 in cell-mediated immunity Annu Rev Immunol 1998 16: 111–135

3. Roy M et al. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells J Immunol 1993 151: 2497–2510

4. Gray D, Siepmann K, Wohlleben G . CD40 ligation in B cell activation, isotype switching and memory development Semin Immunol 1994 6: 303–310

5. Hollenbaugh D et al. The role of CD40 and its ligand in the regulation of the immune response Immunol Rev 1994 138: 23–37

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse CCL9 Chemokine Acts as Tumor Suppressor in a Murine Model of Colon Cancer;Current Issues in Molecular Biology;2023-04-15

2. Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples;Human Gene Therapy;2021-02-01

3. Eotaxins and Their Receptor in Colorectal Cancer—A Literature Review;Cancers;2020-05-28

4. Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses;Molecular Therapy;2020-01

5. CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy;OncoImmunology;2018-08-15